OmegAvail(TM) Synergy
Natural health product licensed in Canada
- Other names
- Omega Complete
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80051433
- Status
- Active licence
- Licence date
- 4 June 2014
- Revision date
- 28 July 2020
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Triacylglycérol lipase Source : Triacylglycerol lipase | 1.5 mg | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 3,300 FCC LU | Not calculated |
| Acide (Z)-9-octadécénoïque Source : Borago officinalis - Graine | 200 mg | Not calculated |
Non-medicinal ingredients
Glycérine, Mélange de concentré de tocophérol, Saveur de citron, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Provides omega 3/6/7/9 fatty acids. A source of omega-3 fatty acids (EPA and DHA) for the maintenance of good health. Contains lipase, a digestive enzyme. Helps maintain/support cardiovascular health. Provides gamma-linolenic acid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking blood thinners, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80051433
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging